| References: |
PFI-4 is a potent and selective BRPF1 bromodomain inhibitor (IC50 = 80 nM). Exhibits >100-fold selectivity for BRPF1 over a panel of other bromodomains including BRPF2 (BRD1), BRPF3 and BRD4. Disrupts BRPF1 binding to histone H3.3. Cell permeable. For the detailed information of PFI-4, the solubility of PFI-4 in water, the solubility of PFI-4 in DMSO, the solubility of PFI-4 in PBS buffer, the animal experiment (test) of PFI-4, the cell expriment (test) of PFI-4, the in vivo, in vitro and clinical trial test of PFI-4, the EC50, IC50,and affinity,of PFI-4, For the detailed information of PFI-4, the solubility of PFI-4 in water, the solubility of PFI-4 in DMSO, the solubility of PFI-4 in PBS buffer, the animal experiment (test) of PFI-4, the cell expriment (test) of PFI-4, the in vivo, in vitro and clinical trial test of PFI-4, the EC50, IC50,and affinity,of PFI-4, Please contact DC Chemicals. |
